About this FactMed analysis covering adverse side effect reports of ALMARL patients who developed HYPOGLYCAEMIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 13 individuals taking ALMARL reported HYPOGLYCAEMIA to the FDA. A total of 227 ALMARL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALMARL and HYPOGLYCAEMIA. In doing so, we compare ALMARL with other drugs that cause HYPOGLYCAEMIA, to help you evaluate whether or not ALMARL causes HYPOGLYCAEMIA. Likewise, this page shows the most highly-reported side effects of ALMARL, so you can see if HYPOGLYCAEMIA ranks among ALMARL's most well-known side effects.
Summary Statistics
Reports of ALMARL causing HYPOGLYCAEMIA: 13
Reports of any side effect of ALMARL : 227
Percentage of ALMARL patients where HYPOGLYCAEMIA is a reported side effect: 5.7269%

FDA reports of any drug causing HYPOGLYCAEMIA : 19480
Average percentage for all medicated patients where HYPOGLYCAEMIA is reported as a complication: 0.1221%

Physician opinion on ALMARL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALMARL:
HYPERTENSION ( 76 patients )
PARKINSON'S DISEASE ( 8 patients )
ESSENTIAL TREMOR ( 6 patients )
ATRIAL FIBRILLATION ( 4 patients )
SCHIZOPHRENIA ( 2 patients )
TREMOR ( 2 patients )
ANGINA PECTORIS ( 2 patients )
DRUG USE FOR UNKNOWN INDICATION ( 2 patients )
PALPITATIONS ( 2 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2 patients )
TACHYCARDIA ( 2 patients )
HYPERTROPHY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HYPOGLYCAEMIA:

LANTUS (3534 patients)
ASPIRIN (2286 patients)
SEROQUEL (2107 patients)
HUMALOG (1637 patients)
METFORMIN HCL (1621 patients)
INSULIN (1272 patients)
GLYBURIDE (1233 patients)
AMARYL (1217 patients)
LASIX (1111 patients)
FUROSEMIDE (899 patients)
JANUVIA (856 patients)
FOSAMAX (832 patients)
BYETTA (802 patients)
SIMVASTATIN (794 patients)
LISINOPRIL (792 patients)
LIPITOR (779 patients)
GLUCOPHAGE (708 patients)
ZYPREXA (661 patients)
ACTOS (639 patients)
OMEPRAZOLE (625 patients)
GLIPIZIDE (620 patients)
AVANDIA (568 patients)
METFORMIN (549 patients)
HEPARIN SODIUM INJECTION (545 patients)
HYDROCHLOROTHIAZIDE (511 patients)
NOVORAPID (495 patients)
SYNTHROID (486 patients)
NORVASC (485 patients)
PLAVIX (483 patients)
ATENOLOL (480 patients)
NOVOLOG (479 patients)
VIOXX (472 patients)
ALLOPURINOL (459 patients)
DIGOXIN (455 patients)
ACETAMINOPHEN (446 patients)
DIOVAN (440 patients)
LEVEMIR (426 patients)
LEVOTHYROXINE SODIUM (414 patients)
HUMULIN R (409 patients)
COUMADIN (409 patients)
ZOCOR (408 patients)
HUMULIN N (408 patients)
RISPERDAL (402 patients)
GLIMEPIRIDE (399 patients)
PREDNISONE (387 patients)
NEURONTIN (377 patients)
AMLODIPINE (348 patients)
TEQUIN (343 patients)
ZOLOFT (331 patients)
RAMIPRIL (328 patients)
NEXIUM (325 patients)
ENALAPRIL MALEATE (325 patients)
POTASSIUM CHLORIDE (311 patients)
HUMALOG MIX 75/25 (308 patients)
XANAX (304 patients)
LYRICA (302 patients)
WARFARIN SODIUM (290 patients)
PAXIL (290 patients)
COZAAR (290 patients)
PREDNISOLONE (287 patients)
FOLIC ACID (283 patients)
ALDACTONE (281 patients)
LANSOPRAZOLE (274 patients)
INSULIN GLARGINE (274 patients)
COREG (274 patients)
APIDRA (270 patients)
SOLOSTAR (269 patients)
METOPROLOL TARTRATE (269 patients)
PROTONIX (264 patients)
DIANEAL (254 patients)
AMBIEN (253 patients)
PREVACID (251 patients)
LEVAQUIN (250 patients)
DEPAKOTE (249 patients)
NOVOLIN R (245 patients)
CARVEDILOL (245 patients)
CRESTOR (244 patients)
ALPRAZOLAM (244 patients)
SPIRONOLACTONE (240 patients)
METFORMIN HYDROCHLORIDE (240 patients)
ALBUTEROL (240 patients)
NITROGLYCERIN (239 patients)
GABAPENTIN (238 patients)
ZOMETA (236 patients)
LEXAPRO (234 patients)
SANDOSTATIN LAR (233 patients)
METOPROLOL (232 patients)
NEXAVAR (229 patients)
GLICLAZIDE (221 patients)
METHOTREXATE (218 patients)
TOPROL-XL (217 patients)
ALTACE (217 patients)
CYMBALTA (214 patients)
CLONAZEPAM (213 patients)
LORAZEPAM (211 patients)
REMICADE (211 patients)
PRILOSEC (210 patients)
MICARDIS (207 patients)
TRAMADOL HCL (206 patients)
CITALOPRAM HYDROBROMIDE (203 patients)
GATIFLOXACIN (201 patients)
AMOXICILLIN (201 patients)
CIPROFLOXACIN (199 patients)
EFFEXOR (196 patients)
IBUPROFEN (195 patients)
ZETIA (192 patients)
CELEXA (191 patients)
BASEN (190 patients)
GLUCOVANCE (188 patients)
BISOPROLOL FUMARATE (187 patients)
GLIBENCLAMIDE (186 patients)
PROZAC (183 patients)
LEVOFLOXACIN (182 patients)
AVELOX (180 patients)
SINGULAIR (179 patients)
ACETYLSALICYLIC ACID SRT (176 patients)
FERROUS SULFATE TAB (176 patients)
WELLBUTRIN (169 patients)
EXTRANEAL (168 patients)
ABILIFY (168 patients)
DEXAMETHASONE (166 patients)
TRAZODONE HCL (165 patients)
PROPRANOLOL (163 patients)
HUMULIN 70/30 (159 patients)
VICODIN (157 patients)
NOVOLIN N (152 patients)
SYMLIN (151 patients)
CLONIDINE (151 patients)
AMITRIPTYLINE HCL (150 patients)
ATIVAN (150 patients)
METOCLOPRAMIDE (150 patients)
AMLODIPINE BESYLATE (147 patients)
TEMAZEPAM (146 patients)
GEODON (146 patients)
PREDNISONE TAB (146 patients)
CLARITHROMYCIN (146 patients)
PERCOCET (145 patients)
NOVOLOG MIX 70/30 (145 patients)
FAMOTIDINE (144 patients)
RANITIDINE (144 patients)
RISPERIDONE (143 patients)
CELEBREX (143 patients)
CAPTOPRIL (142 patients)
DIAZEPAM (142 patients)
ADVAIR DISKUS 100/50 (141 patients)
DIAMICRON (141 patients)
REGLAN (141 patients)
ATORVASTATIN CALCIUM (141 patients)
ZANTAC (140 patients)
NPH INSULIN (138 patients)
PEPCID (137 patients)
ACCUTANE (136 patients)
ADALAT (135 patients)
GLUCOBAY (135 patients)
PREDONINE (134 patients)
NOVORAPID CHU FLEXPEN (133 patients)
ATORVASTATIN (133 patients)
ZOFRAN (133 patients)
VERAPAMIL (131 patients)
NIFEDIPINE (131 patients)
MAGNESIUM OXIDE (131 patients)
KLONOPIN (130 patients)
LORTAB (128 patients)
GLEEVEC (128 patients)
TRICOR (126 patients)
FLUCONAZOLE (126 patients)
[THERAPY UNSPECIFIED] (126 patients)
OXYCODONE HCL (125 patients)
CLOPIDOGREL (125 patients)
OPTICLIK (INSULIN INJECTION PEN) (124 patients)
AREDIA (124 patients)
IRBESARTAN (123 patients)
METOPROLOL SUCCINATE (123 patients)
COLACE (123 patients)
VITAMIN D (123 patients)
LOPRESSOR (121 patients)
MORPHINE (121 patients)
ZYRTEC (121 patients)
DECADRON (120 patients)
ENALAPRIL (119 patients)
REGULAR INSULIN (119 patients)
GLUCOTROL (119 patients)
REPAGLINIDE (119 patients)
TORSEMIDE (119 patients)
OPTIPEN (INSULIN PUMP) (118 patients)
PANTOPRAZOLE SODIUM (118 patients)
TOPAMAX (118 patients)
FORTEO (118 patients)
LOSARTAN POTASSIUM (117 patients)
NAPROXEN (116 patients)
VALSARTAN (116 patients)
CALCIUM CARBONATE (116 patients)
PRAVASTATIN (115 patients)
LAMICTAL (115 patients)
HEPARIN (115 patients)
NOVONORM (115 patients)
HYDROCORTISONE (114 patients)
VELCADE (113 patients)
VYTORIN (113 patients)
LOVENOX (112 patients)
AMIODARONE HCL (112 patients)
HUMIRA (112 patients)
FLUOXETINE (111 patients)
ALLEGRA (111 patients)
NOVORAPID FLEXPEN (110 patients)
ACTRAPID (110 patients)
MUCOSTA (110 patients)
VICTOZA (109 patients)
AVAPRO (108 patients)
PANTOPRAZOLE (107 patients)
Most common side effects for patients taking ALMARL:
DEPRESSED LEVEL OF CONSCIOUSNESS (20 patients)
HALLUCINATION (15 patients)
FALL (13 patients)
HYPOGLYCAEMIA (13 patients)
PYREXIA (12 patients)
TREMOR (12 patients)
DIARRHOEA (11 patients)
HEPATIC FUNCTION ABNORMAL (11 patients)
PNEUMONIA (10 patients)
DYSARTHRIA (10 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (9 patients)
RENAL FAILURE ACUTE (9 patients)
LIVER DISORDER (9 patients)
CEREBRAL INFARCTION (8 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (8 patients)
DRUG INEFFECTIVE (8 patients)
RENAL IMPAIRMENT (8 patients)
HYPONATRAEMIA (8 patients)
INTERSTITIAL LUNG DISEASE (8 patients)
JAUNDICE (8 patients)
OEDEMA PERIPHERAL (8 patients)
CONDITION AGGRAVATED (7 patients)
DELIRIUM (7 patients)
DYSPHAGIA (7 patients)
DYSPNOEA (7 patients)
HYPOAESTHESIA (7 patients)
RHABDOMYOLYSIS (7 patients)
VOMITING (6 patients)
DELUSION (6 patients)
RESPIRATORY FAILURE (6 patients)
DYSKINESIA (6 patients)
SOMNOLENCE (6 patients)
HEPATIC NEOPLASM MALIGNANT (6 patients)
HYPERGLYCAEMIA (6 patients)
HYPOKALAEMIA (6 patients)
MOVEMENT DISORDER (6 patients)
MUSCULAR WEAKNESS (6 patients)
WHITE BLOOD CELL COUNT INCREASED (5 patients)
BLADDER CANCER (5 patients)
BLOOD ANTIDIURETIC HORMONE INCREASED (5 patients)
RESTLESSNESS (5 patients)
BLOOD OSMOLARITY DECREASED (5 patients)
PLEURAL EFFUSION (5 patients)
C-REACTIVE PROTEIN INCREASED (5 patients)
CONVULSION (5 patients)
RENAL DISORDER (5 patients)
VITH NERVE PARALYSIS (5 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (5 patients)
INTESTINAL OBSTRUCTION (5 patients)
SEPSIS (5 patients)
ROAD TRAFFIC ACCIDENT (5 patients)
MUSCULOSKELETAL PAIN (5 patients)
NAUSEA (5 patients)
ANOREXIA (4 patients)
ATELECTASIS (4 patients)
ATRIAL FIBRILLATION (4 patients)
ATRIOVENTRICULAR BLOCK (4 patients)
BLOOD CREATININE INCREASED (4 patients)
BRADYCARDIA (4 patients)
CARDIAC FAILURE (4 patients)
CONSTIPATION (4 patients)
DECREASED APPETITE (4 patients)
DEHYDRATION (4 patients)
DIZZINESS (4 patients)
PLATELET COUNT DECREASED (4 patients)
PAIN (4 patients)
HYPERTENSION (4 patients)
HYPOTHYROIDISM (4 patients)
ILEUS (4 patients)
METABOLIC ACIDOSIS (4 patients)
SMALL INTESTINE CARCINOMA (4 patients)
URINE OSMOLARITY INCREASED (4 patients)
ABASIA (3 patients)
AGGRESSION (3 patients)
PRURITUS (3 patients)
ANAEMIA (3 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (3 patients)
WHITE BLOOD CELL COUNT DECREASED (3 patients)
ASTHMA (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
RENAL FAILURE (3 patients)
BLOOD PRESSURE DECREASED (3 patients)
BLOOD PRESSURE INCREASED (3 patients)
VASCULITIS (3 patients)
CAROTID ARTERY STENOSIS (3 patients)
THERAPEUTIC AGENT TOXICITY (3 patients)
CHILLS (3 patients)
CHROMATURIA (3 patients)
PETECHIAE (3 patients)
CHRONIC LYMPHOCYTIC LEUKAEMIA (3 patients)
PORIOMANIA (3 patients)
RENAL ARTERY STENOSIS (3 patients)
PANCYTOPENIA (3 patients)
DRUG ERUPTION (3 patients)
SUDDEN ONSET OF SLEEP (3 patients)
DRUG WITHDRAWAL SYNDROME (3 patients)
VERTIGO (3 patients)
EPILEPSY (3 patients)
FACE OEDEMA (3 patients)
VOLVULUS (3 patients)
GENERALISED OEDEMA (3 patients)
GINGIVAL BLEEDING (3 patients)
HAEMORRHAGE SUBCUTANEOUS (3 patients)
HALLUCINATION, VISUAL (3 patients)
PSYCHIATRIC SYMPTOM (3 patients)
HEART RATE DECREASED (3 patients)
HELICOBACTER TEST POSITIVE (3 patients)
HEPATITIS FULMINANT (3 patients)
HYPERKALAEMIA (3 patients)
HYPOTENSION (3 patients)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (3 patients)
LOSS OF CONSCIOUSNESS (3 patients)
SENSORY DISTURBANCE (3 patients)
LYMPHOMA (3 patients)
MALAISE (3 patients)
MARKEDLY REDUCED DIETARY INTAKE (3 patients)
RENAL TUBULAR DISORDER (3 patients)
NEOPLASM MALIGNANT (3 patients)
SINUS ARREST (3 patients)
ABDOMINAL DISCOMFORT (2 patients)
ABDOMINAL PAIN (2 patients)
ACUTE MYELOID LEUKAEMIA (2 patients)
STOMACH MASS (2 patients)
PERSONALITY CHANGE (2 patients)
AGITATION (2 patients)
ALTERED STATE OF CONSCIOUSNESS (2 patients)
ANAPHYLACTOID REACTION (2 patients)
ANGER (2 patients)
PRODUCTIVE COUGH (2 patients)
RENAL CYST (2 patients)
APHASIA (2 patients)
ASTHENIA (2 patients)
ATRIOVENTRICULAR BLOCK COMPLETE (2 patients)
THIRST (2 patients)
PROSTATE CANCER (2 patients)
BLOOD AMYLASE INCREASED (2 patients)
BLOOD UREA INCREASED (2 patients)
BODY TEMPERATURE INCREASED (2 patients)
SPEECH DISORDER (2 patients)
TUMOUR LYSIS SYNDROME (2 patients)
CEREBRAL HAEMORRHAGE (2 patients)
CHEST X-RAY ABNORMAL (2 patients)
COLON CANCER (2 patients)
COMA HEPATIC (2 patients)
COMPLETED SUICIDE (2 patients)
CONTUSION (2 patients)
PERFORMANCE STATUS DECREASED (2 patients)
DEFAECATION URGENCY (2 patients)
DEMENTIA ALZHEIMER'S TYPE (2 patients)
RASH PRURITIC (2 patients)
DIABETIC KETOACIDOSIS (2 patients)
DRUG INTERACTION (2 patients)
DRUG LEVEL INCREASED (2 patients)
DYSPEPSIA (2 patients)
DYSSTASIA (2 patients)
ELECTROCARDIOGRAM QT PROLONGED (2 patients)
STEVENS-JOHNSON SYNDROME (2 patients)
EPULIS (2 patients)
EXTRAOCULAR MUSCLE PARESIS (2 patients)
FACIAL PARESIS (2 patients)
FEAR (2 patients)
FEBRILE NEUTROPENIA (2 patients)
FEMORAL NECK FRACTURE (2 patients)
FOOT FRACTURE (2 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (2 patients)
GANGRENE (2 patients)
GASTRIC ULCER HAEMORRHAGE (2 patients)
GINGIVAL HYPERTROPHY (2 patients)
GLOSSOPTOSIS (2 patients)
PLEURISY (2 patients)
PHRENIC NERVE PARALYSIS (2 patients)
HAEMATEMESIS (2 patients)
HAEMATURIA (2 patients)
HAEMOGLOBIN DECREASED (2 patients)
POLLAKIURIA (2 patients)
ORAL INTAKE REDUCED (2 patients)
HEPATIC CYST (2 patients)
HEPATIC ENCEPHALOPATHY (2 patients)
HEPATITIS (2 patients)
HYPERREFLEXIA (2 patients)
HYPERTONIA (2 patients)
HYPERURICAEMIA (2 patients)
RASH PAPULAR (2 patients)
INITIAL INSOMNIA (2 patients)
RETINAL OEDEMA (2 patients)
INTESTINAL FUNCTIONAL DISORDER (2 patients)
RESPIRATION ABNORMAL (2 patients)
IRRITABILITY (2 patients)
RIB FRACTURE (2 patients)
LEG AMPUTATION (2 patients)
LYMPHADENOPATHY (2 patients)
METABOLIC ALKALOSIS (2 patients)
ORAL HERPES (2 patients)
TAKAYASU'S ARTERITIS (2 patients)
MOUTH HAEMORRHAGE (2 patients)
UNRESPONSIVE TO STIMULI (2 patients)
TOXIC SKIN ERUPTION (2 patients)
NEPHROLITHIASIS (2 patients)
SUICIDE ATTEMPT (2 patients)
VENTRICULAR FIBRILLATION (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
UPPER RESPIRATORY TRACT INFECTION (2 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (2 patients)
SHOCK HAEMORRHAGIC (2 patients)
ABDOMEN CRUSHING (1 patients)
CARDIAC FAILURE CONGESTIVE (1 patients)
EOSINOPHILIC PNEUMONIA ACUTE (1 patients)
ESSENTIAL TREMOR (1 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (1 patients)
FUNGAL INFECTION (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALMARL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HYPOGLYCAEMIA and ALMARL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALMARL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALMARL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALMARL experts. If you are a healthcare provider experienced in prescribing ALMARL, please register here.

Your online appointment book for Peabody Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use